Syngenta seeks $20bn loan: but is it ChemChina risk?

The unusual financing structure that China National Chemical Corp (ChemChina) is using for its $43bn acquisition of Syngenta drew a varied response from banks in Europe this week. Some saw the non-recourse structure for $20bn of the debt as shielding lenders from exposure to ChemChina, while others did not.